MassDevice.com +3 | The top 3 medtech stories for September 22, 2015

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. TransEnterix puts up $100m for Sofar’s ALF-X robot-assisted surgery device TransEnterix said that it acquired the Telelap ALF-X robot-assisted surgery device from Italy’s Sofar SpA in a deal worth $99.8 million. The Telelap ALF-X device has CE Mark approval in the European Union for minimally invasive surgery procedures. Research Triangle Park, N.C.-based TransEnterix makes the SurgiBot robot-assisted surgery device. The deal included $25 million in up-front cash and some 15.5 million TRXC shares worth another $43.7 million, the companies said. Another $31.1 million (€27.5 million) is on the line in potential milestones, according to the companies. Read more 2. Medtronic launches real-world study for SuperDimension lung device Medtronic said that it launched a huge, real-world study of the SuperDimension lung device it acquired along with Covidien earlier this year. The 2-year, 2,500-patient Navigate trial is designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The single-arm, multi-center post-market observational study a...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 3 Source Type: news